BrightInsight

BrightInsight is a prominent provider in the digital health sector, offering a specialized platform tailored for the biopharma and medtech industries. The company delivers a range of solutions, such as Disease Management, Software as a Medical Device (SaMD), and Data & Insights. It focuses on various therapeutic areas including diabetes, oncology, and immunology. BrightInsight supports its development process with the expertise of a Clinical Board and Patient Advisors, ensuring that its offerings are both clinically relevant and patient-centric. The company has developed 14 SaMD solutions and operates across 11 different therapy areas. It has also established strong partnerships with six of the top ten biopharma companies globally. BrightInsight’s excellence in digital health has been recognized by Newsweek, listing it among the World’s Best Digital Health Companies for the year 2024.